Welcome to the
Pascoal Lab
About the
Lab
Our lab is interested in the quantification of brain pathophysiology in patients with Alzheimer’s disease (AD) and related dementias as well as in the validation of therapies capable of modifying the course of these diseases producing an enduring disease-modifying and clinically relevant effect. This involves the validation of positron emission tomography (PET) and fluid biomarker techniques capable of measuring these brain pathologies and monitoring their progression.
Research in
Focus
Recent
Publications
The Lancet
Comparison of [18F]flortaucipir and [18F]MK6240 for the detection of tau pathology in Alzheimer’s disease (HEAD): a multicentre, prospective, cross-sectional, within-participant study
Jama Neurology
A Harmonized Visual Reading Framework for Tau PET Staging in Alzheimer Disease
Molecular Neurodegeneration
Astrocyte reactivity identifies p-tau217-positive individuals at elevated risk of cognitive decline across the Alzheimer’s disease continuum
The Lancet
Alzheimer’s disease
The Lancet Medical Imaging & Theranostics
Low-dose CT for MRI-free quantification of tau PET in Alzheimer’s disease: a multicentre, cross-sectional, comparison study
Jama Network
Age at Diagnosis and Clinical and Genetic Profiles Among Adults With Attention-Deficit/Hyperactivity Disorder
Stay Tuned
News
Funding
Affiliations
Funding
Affiliations